Emanuela Felley-Bosco

Pleural mesothelioma side populations have a precursor phenotype.

Proteomic surfaceome analysis of mesothelioma.

Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.

Role of hedgehog signaling in malignant pleural mesothelioma.

Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy.

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring.

PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.

GAS5 long non-coding RNA in malignant pleural mesothelioma.

Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.

Hedgehog Signaling in Malignant Pleural Mesothelioma.

Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models.

Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.

Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.

Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.

Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.

Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.

Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.

A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.

Long Noncoding RNAs in Cancer and Therapeutic Potential.

Erratum to: Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.

How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations.

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.

Non-Coding Transcript Heterogeneity in Mesothelioma: Insights from Asbestos-Exposed Mice.